Shin Nippon Biomedical Laboratories, Ltd. (2395) Ownership - Who Owns Shin Nippon Biomedical Laboratories, Ltd.?

Q: What percentage of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is held by retail investors?

According to the latest TipRanks data, approximately 96.11% of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is held by retail investors.

Q: Who owns the most shares of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)?

Vanguard owns the most shares of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. (2395) Ownership Overview

1.59%

Mutual Funds

2.30% ETFs

96.11% Public Companies and

Individual Investors

The ownership structure of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is a mix of institutional, retail, and individual investors. , and 96.11% is owned by Public Companies and Individual Investors.

The ownership structure of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is a mix of institutional, retail, and individual investors. Approximately 98.41% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
580,961	Institution	1.40%	5,310,565
262,604	Institution	0.63%	2,400,463
252,900	Institution	0.61%	2,311,759
187,921	Institution	0.45%	1,717,786
104,710	Institution	0.25%	957,154
103,700	Institution	0.25%	947,922
37,638	Institution	0.09%	344,049
29,900	Institution	0.07%	273,316
22,100	Institution	0.05%	202,016
14,097	Institution	0.03%	128,861

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
262,604	Institution	0.63%	2,400,463
187,921	Institution	0.45%	1,717,786
104,710	Institution	0.25%	957,154
103,700	Institution	0.25%	947,922
2,800	Institution	<0.01%	25,595

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total International Stock ETF	280,604	Institution	0.67%	3,070,566
Vanguard FTSE Developed Markets ETF	187,921	Institution	0.45%	2,056,363
WisdomTree Japan Hedged Equity Fund	141,200	Institution	0.34%	1,289,047
Vanguard FTSE All-World ex-US Small-Cap ETF	71,000	Institution	0.17%	776,932
Schwab International Small-Cap Equity ETF	37,638	Institution	0.09%	348,175
Vanguard FTSE Pacific ETF	25,110	Institution	0.06%	274,771
WisdomTree Japan SmallCap Dividend Fund	21,900	Institution	0.05%	199,930
Dimensional International Small Cap ETF	18,700	Institution	0.04%	170,717
Avantis International Small Cap Value ETF	17,200	Institution	0.04%	157,239
CI WisdomTree Japan Equity Index ETF	14,097	Institution	0.03%	189,231

FAQ

Who Owns Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)?

Currently, no data Available

What percentage of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is held by institutional investors?

Currently, no data Available

What percentage of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is held by retail investors?

According to the latest TipRanks data, approximately 96.11% of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) stock is held by retail investors.

Who owns the most shares of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)?

Vanguard owns the most shares of Shin Nippon Biomedical Laboratories, Ltd. (JP:2395).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.